The therapeutic effects of marine sulfated polysaccharides on diabetic nephropathy

被引:3
|
作者
Wu, Lijuan [1 ,2 ,3 ]
Zhang, Xiaonan [2 ,3 ]
Zhao, Jun [2 ,3 ]
Yang, Menglin [2 ,3 ]
Yang, Jinbo [1 ,2 ,3 ]
Qiu, Peiju [1 ,2 ,3 ]
机构
[1] Ocean Univ China, Sch Med & Pharm, Chinese Minist Educ, Key Lab Marine Drugs, Yushan Rd, Qingdao 266003, Peoples R China
[2] Pilot Natl Lab Marine Sci & Technol Qingdao, Ctr Innovat Marine Drug Screening &Evaluat, Qingdao 266237, Peoples R China
[3] Marine Biomed Res Inst Qingdao, Qingdao 266071, Peoples R China
关键词
Marine sulfated polysaccharide; Diabetic nephropathy; Mechanisms; Structure-activity relationship; MOLECULAR-WEIGHT FUCOIDAN; EPITHELIAL-MESENCHYMAL TRANSITION; FIBROBLAST-GROWTH-FACTOR; P-SELECTIN; STRUCTURAL-CHARACTERIZATION; ENDOTHELIAL GLYCOCALYX; HEPARANASE; BINDING; SULODEXIDE; DISEASE;
D O I
10.1016/j.ijbiomac.2024.129269
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Marine sulfated polysaccharide (MSP) is a natural high molecular polysaccharide containing sulfate groups, which widely exists in various marine organisms. The sources determine structural variabilities of MSPs which have high security and wide biological activities, such as anticoagulation, antitumor, antivirus, immune regulation, regulation of glucose and lipid metabolism, antioxidant, etc. Due to the structural similarities between MSP and endogenous heparan sulfate, a majority of studies have shown that MSP can be used to treat diabetic nephropathy (DN) in vivo and in vitro. In this paper, we reviewed the anti-DN activities, the dominant mechanisms and structure-activity relationship of MSPs in order to provide the overall scene of MSPs as a modality of treating DN.
引用
收藏
页数:12
相关论文
共 50 条
  • [41] THERAPEUTIC INTERVENTIONS IN THE PROGRESSION OF DIABETIC NEPHROPATHY
    LEWIS, EJ
    AMERICAN JOURNAL OF HYPERTENSION, 1994, 7 (09) : S93 - S95
  • [42] Clinical and therapeutic aspects of diabetic nephropathy
    Strippoli, GF
    Di Paolo, S
    Cincione, R
    Di Palma, AM
    Teutonico, A
    Grandaliano, G
    Schena, FP
    Gesualdo, L
    JOURNAL OF NEPHROLOGY, 2003, 16 (04) : 487 - 499
  • [43] Autophagy as a Therapeutic Target in Diabetic Nephropathy
    Tanaka, Yuki
    Kume, Shinji
    Kitada, Munehiro
    Kanasaki, Keizo
    Uzu, Takashi
    Maegawa, Hiroshi
    Koya, Daisuke
    EXPERIMENTAL DIABETES RESEARCH, 2012,
  • [44] CURRENT THERAPEUTIC MANAGEMENT OF DIABETIC NEPHROPATHY
    KOHLER, SM
    KRAMER, BK
    ACTA DIABETOLOGICA, 1994, 31 (03) : 119 - 125
  • [45] New therapeutic agents in diabetic nephropathy
    Kim, Yaeni
    Park, Cheol Whee
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2017, 32 (01): : 11 - 25
  • [46] Diabetic nephropathy: newer therapeutic perspectives
    Keri, Krishna C.
    Samji, Naga S.
    Blumenthal, Samuel
    JOURNAL OF COMMUNITY HOSPITAL INTERNAL MEDICINE PERSPECTIVES, 2018, 8 (04): : 200 - 207
  • [47] Transplantation as a therapeutic option for diabetic nephropathy
    Peeters, P
    Vanholder, R
    ACTA CLINICA BELGICA, 2004, 59 (03): : 125 - 133
  • [48] Therapeutic potential of angiostatin in diabetic nephropathy
    Zhang, Sarah X.
    Wang, Joshua J.
    Lu, Kangmo
    Mott, Robert
    Longeras, Richard
    Ma, Jian-xing
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2006, 17 (02): : 475 - 486
  • [49] Marine polysaccharides: therapeutic efficacy and biomedical applications
    Young-Eun Lee
    Hyeongmin Kim
    Changwon Seo
    Taejun Park
    Kyung Bin Lee
    Seung-Yup Yoo
    Seong-Chul Hong
    Jeong Tae Kim
    Jaehwi Lee
    Archives of Pharmacal Research, 2017, 40 : 1006 - 1020
  • [50] Marine polysaccharides: therapeutic efficacy and biomedical applications
    Lee, Young-Eun
    Kim, Hyeongmin
    Seo, Changwon
    Park, Taejun
    Lee, Kyung Bin
    Yoo, Seung-Yup
    Hong, Seong-Chul
    Kim, Jeong Tae
    Lee, Jaehwi
    ARCHIVES OF PHARMACAL RESEARCH, 2017, 40 (09) : 1006 - 1020